Saurabh Saha - Dec 31, 2023 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Executive Officer, Director
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Stock symbol
CNTA
Transactions as of
Dec 31, 2023
Transactions value $
-$288,653
Form type
4
Date filed
1/2/2024, 07:43 PM
Previous filing
Oct 3, 2023
Next filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Tax liability -$289K -36.3K -4.41% $7.96 787K Dec 31, 2023 Direct F1, F2
holding CNTA Ordinary Shares 38K Dec 31, 2023 By trust F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
F3 These shares are held directly in a trust, for which the reporting person and his spouse serve as trustees.